Baird Medical Investment Holdings Ltd (BDMD) stock
Close on Nov 11, 2026Market cap $4.26MP/E –Yield –
Baird Medical Investment Holdings Ltd saw revenue fall 39.2% to $22.54M over fiscal 2025. Operating income fell 267.4% to -$25.63M, moving the operating margin from 41.4% to -113.7%. Free cash flow was -$1.39M. At the latest close the market valued the company at $4.26M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $4.26M
- P/E ratio
- –
- Price to sales
- 0.19
- Price to book
- 0.12
- Dividend yield
- –
- Free cash flow yield
- -32.53%
Fundamentals
- Revenue
- $22.54M
- Net income
- -$27.28M
- EPS, diluted
- -$0.98
- Free cash flow
- -$1.39M
Trading
- Previous close
- $0.10
- Open
- $0.11
- Day's range
- $0.09 – $0.16
- Volume
- 151,164,800
- Average volume (20 days)
- 44,159,286
- Beta (5 years)
- -0.04
- 52-week range
- $0.07 – $3.70
- RSI (14 days)
- 22.2
- Volatility (1 year)
- 147.6%
- Relative volume
- 18.49×
- WACC
- 5.1%
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BDMD | S&P 500 | Difference | BDMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -86.5% | -2.4% | −84.1 pts | ||
| 3 months | -91.1% | -1.2% | −90.0 pts | ||
| Year to date | -92.4% | +12.3% | −104.6 pts | ||
| 1 year | -91.6% | +12.4% | −104.1 pts | ||
| 3 years | -99.0% | +78.8% | −177.8 pts | -78.6% | +21.4% |
Five years at a glance
Fiscal years 2021 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Baird Medical Investment filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Baird Medical Investment
Surgical & Medical Instruments & Apparatus
Baird Medical develops, manufactures, and commercializes proprietary microwave ablation medical devices focused primarily on thyroid diseases and tumor treatments. Its core products include microwave ablation therapeutic systems and single-use long and fine ablation needles designed for minimally invasive procedures. In addition to proprietary ablation technology, the business distributes third-party medical supplies, including ventilators, catheters, surgical tables, and disposable gloves. The company sells its medical apparatus to healthcare institutions, medical device distributors, and hospital deliverers.
Company profile, executives and historyBaird Medical Investment stock: common questions
What is Baird Medical Investment's stock price?
BDMD closed at $0.10 on Nov 11, 2026, up 7.22% on the day. Over the past 52 weeks it traded between $0.07 and $3.70.
What is Baird Medical Investment's market cap?
Baird Medical Investment was worth $4.26M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is BDMD's P/E ratio?
Baird Medical Investment lost money over fiscal 2025 (diluted EPS -$0.98), so it has no meaningful P/E ratio.
How much revenue does Baird Medical Investment make?
Baird Medical Investment reported revenue of $22.54M for fiscal 2025, down 39.2% from a year earlier.
Does Baird Medical Investment pay a dividend?
No. Baird Medical Investment has not paid a cash dividend over the last twelve months.
How has BDMD stock performed over the past year?
Including dividends, BDMD returned -91.6% over the past year, against +12.4% for the S&P 500.
Who are Baird Medical Investment's competitors?
Companies most similar to Baird Medical Investment by business, industry and size include PROF, WOK, UTMD, SRTS, SNOA.
See a number that looks wrong?